Effects of transforming growth factor-β1 and its receptor on the development, recurrence and progression of human bladder cancer

Korean Journal of Urology

Volumn 47, Issue 4, 2006, Pages 426-435

  Quan, Changyi ^a,b   Park, Moon Seon ^a,b   Jo, Sung Whan ^a,b   Lee, Sang Cheol ^a,b   Kim, Wun Jae ^a,b  

^a Chungbuk National University College of Medicine   (South Korea)

^b Korea University   (South Korea)

Author keywords

Bladder cancer; TGF beta receptor; Transforming growth factor 1

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; PARAFFIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; BLADDER MUCOSA; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER RESISTANCE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE FREE SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STUDENT T TEST; TISSUE LEVEL;

EID: 33745621569     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2006.47.4.426     Document Type: Article

References (30)

1. Messing EM. Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ, editors. Campbell's urology. 8th ed. Pennsylvania: Saunders; 2002;2750-1
2. Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-29
3. Akhurst RJ, Derynck R. TGF-β signaling in cancer-a double-edged sword. Trends Cell Biol 2001;11:S44-51
4. Wakefield LM, Roberts AB. TGF-β signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 2002;12:22-9
5. Akhurst RJ. TGF-β antagonists: why suppress a tumor suppressor? J Clin Invest 2002;109:1533-6
6. Zhang HT, Chen XF, Wang MH, Wang JC, Qi QY, Zhang RM, et al. Defective expression of transforming growth factor β receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer. Clin Cancer Res 2004;10:2359-67
7. Kaklamani VG, Pasche B. Role of TGF-β in cancer and the potential for therapy and prevention. Expert Rev Anticancer Ther 2004;4:649-61
8. Massagué J, Blain SW, Lo RS. TGF-β signaling in growth control, cancer, and heritable disorders. Cell 2000;103:295-309
9. Pinto M, Oliveira C, Cirnes L, Carlos Machado J, Ramires M, Nogueira A, et al. Promoter methylation of TGF-β receptor I and mutation of TGF β receptor II are frequent events in MSI sporadic gastric carcinomas. J Pathol 2003;200:32-8
10. Miyaki M, Iijima T, Konishi M, Sakai K, Ishii A, Yasuno M, et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 1999;18:3098-103
11. Derynck R, Feng XH. TGF-β receptor signaling. Biochim Biophys Acta 1997;1333:F105-50
12. Gold LI. The role for transforming growth factor-beta (TGF-β) in human cancer. Crit Rev Oncog 1999;10:303-60
13. Eder IE, Stenzl A, Hobisch A, Cronauer MV, Bartsch G, Klocker H. Expression of transforming growth factors beta-1, beta-2 and beta-3 in human bladder carcinomas. Br J Cancer 1997;75:1753-60
14. Miyamoto H, Kubota Y, Shuin T, Torigoe S, Dobashi Y, Hosaka M. Expression of transforming growth factors beta-1 in human bladder cancer. Cancer 1995;75:2565-70
15. Kim JH, Shariat SF, Kim IY, Menesses-Diaz A, Tokunaga H, Wheeler TM, et al. Predictive value of expression of transforming growth factor-β (1) and its receptors in transitional cell carcinoma of the urinary bladder. Cancer 2001;92:1475-83
16. Izadifar V, de Boer WI, Muscatelli-Groux B, Maille P, van der Kwast TH, Chopin D. Expression of transforming growth factor β1 and its receptors in normal human urothelium and human transitional cell carcinomas. Hum Pathol 1999;30:372-7
17. Celi FS, Zenilman ME, Shuldiner AR. A rapid and versatile method to synthesize internal standards for competitive PCR. Nucleic Acids Res 1993;21:1047
18. Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989;86:9717-21
19. Becker-Andre M, Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res 1989;17:9437-46
20. Gilliland G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 1990;87:2725-9
21. Kim SH, Kook MC, Shin YK, Park SH, Song HG. Evaluation of antigen retrieval buffer systems. J Mol Histol 2004;35:409-16
22. Kim SH, Shin YK, Lee KM, Lee JS, Yun JH, Lee SM. An improved protocol of biotinylated tyramine-based immunohistochemistry minimizing nonspecific background staining. J Histochem Cytochem 2003;51:129-32
23. Sinicrope FA, Ruan SB, Cleary KB, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995;55:237-41
24. Saji H, Nakamura H, Awut I, Kawasaki N, Hagiwara M, Ogata A, et al. Significance of expression of TGF-β in pulmonary metastasis in non-small cell lung cancer tissues. Ann Thorac Cardiovasc Surg 2003;9:295-300
25. Tang B, Vu M, Booker T, Santner SJ, Miller FR, Anver MR, et al. TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 2003;112:1116-24
26. Kang SH, Bang YJ, Im YH, Yang HK, Lee DA, Lee HY, et al. Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer. Oncogene 1999;18:7280-6
27. Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE. Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res 1998;58:5329-32
28. Bello-DeOcampo D, Tindall DJ. TGF-beta1/Smad signaling in prostate cancer. Curr Drug Targets 2003;4:197-207
29. Lee C, Sintich SM, Mathews EP, Shah AH, Kundu SD, Perry KT, et al. Transforming growth factor-beta in benign and malignant prostate. Prostate 1999;39:285-90
30. Eder IE, Stenzl A, Hobisch A, Cronauer MV, Bartsch G, Klocker H. Transforming growth factors beta-1 and beta-2 in serum and urine from patients with bladder cancer. J Urol 1996;156:953-7